HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • 2023 Salary Survey
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists

Parexel VPs Discuss COVID-19, RWE, and New Challenges

Parexel’s Leanne Larson and Matthew Gordon shared their thoughts on the growing importance of real world evidence (RWE) in clinical research and in regulatory approval. They also discussed how the COVID-19 pandemic has accelerated the adoption of RWE and put a spotlight on how real world data (RWD) […]

more info 11/01/2021View Related Articles
Bookmark and Share

AMCP Partnership Forum on Biosimilars Identifies Adoption Challenges and RWE Solutions

The Academy of Managed Care Pharmacy (AMCP) Partnership Forum met in December 2020 to discuss the use of biosimilars in healthcare. The cross-disciplinary stakeholders examined barriers to biosimilar use in the United States and how real world evidence (RWE), among other strategies, can advance […]

more info 10/28/2021View Related Articles
Bookmark and Share

Collaborative RWE Registry Promises Data Transparency

The Real World Evidence (RWE) Registry was formed by the International Society for Pharmacoeconomics and Outcomes (ISPOR), the International Society for Pharmacoepidemiology (ISPE), the National Pharmaceutical Council (NPC), and the Duke-Margolis Center for Health Policy. The registry is intended to […]

more info 10/27/2021View Related Articles
Bookmark and Share

Newly Launched Cerner Enviza Utilizes RWD to Advance R&D, Improve Patient Outcomes, and Reduce Healthcare Costs

Cerner has launched Cerner Enviza, an operating unit that will use real world data (RWD) to advance clinical research and improve patient care. The initiative is also expected to reduce healthcare costs and improve health equity. Cerner President and CEO David Feinberg remarks, “The true promise […]

more info 10/26/2021View Related Articles
Bookmark and Share

Savana CEO and Founder Discusses Overcoming RWE Challenges and Ensuring Data Privacy

Savana CEO and Founder discussed challenges that arise when designing real world evidence (RWE) studies, including data privacy concerns, data ownership, and performing high quality studies using artificial intelligence (AI). Savana has been remarkably successful in extracting useful real world data […]

more info 10/25/2021View Related Articles
Bookmark and Share

RWE Brings Data Privacy Concerns and Solutions

The use of real world evidence (RWE) has put a spotlight on data privacy and regulatory concerns. Regulatory expert Jackie Mulryne and former European Medicines Agency legal advisor Alexander Roussanov share their thoughts on essential steps for RWE studies, including deidentifying patient data and […]

more info 10/25/2021View Related Articles
Bookmark and Share

Investigators Use RWD to Identify Potential Alzheimer’s Drug

According to a new study using data from electronic health records (EHRs), bumetanide, a diuretic, could be used in patients with Alzheimer’s disease. The real world data (RWD) study sought to identify drugs already approved by the Food and Drug Administration (FDA) for other […]

more info 10/25/2021View Related Articles
Bookmark and Share

ISPOR Article on the Growing Wearable Market and New Applications in Healthcare

A recent article featured in Value & Outcomes Spotlight details the growing use of wearables. These tools can be an important source of real world data (RWD) in clinical trials and in patients at risk of developing severe or worsening disease. In addition, payers are increasingly interested in […]

more info 10/22/2021View Related Articles
Bookmark and Share

HealthVerity’s RWD Platform Informs Government Response to COVID-19

HealthVerity’s IPGE platform has been a critical source of real world data (RWD) for public health agencies throughout the COVID-19 pandemic, including the Centers for Disease Control (CDC) and the Food and Drug Administration (FDA). “Throughout the pandemic, public health agencies contracted […]

more info 10/22/2021View Related Articles
Bookmark and Share

Register for Upcoming Webinar on RWD in Decentralized Clinical Trials

A webinar highlighting the benefits of decentralized clinical trials that incorporate real world data (RWD) will take place on November 1st at 12:00 PM EST. The webinar will feature important insights from leading data experts at EVERSANA, THREAD, Protocol First, and Datavant. “Decentralized […]

more info 10/20/2021View Related Articles
Bookmark and Share

  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 14
  • Next Page

 

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • Assistant Director - Oncology Strategy & Communications (Remote)
  • Senior Director - Evidence Generation & Value Communications (Remote)
  • Medical Writer
  • Senior Biostatistician, Statistical Analytics
  • Senior Director, Evidence Synthesis
 
Syndicated Reports

Biotech R&D: a target-rich environment

Global Gene Therapy Report 2022-2031

ePrescribing Market – This is How Key Players are Dominating Global Industry

Health Economics and Outcomes Research (HEOR) Services Market to 2028

 
White Papers

Real World Evidence Solutions Global Market Report 2022

AI for Pharma and Biotech Market Pricing Strategy, Industry Latest News, Top Company Analysis, Research Report Analysis and Share by Forecast 2026

Whitepaper – Engaging the End Prescriber: A Practical Guide to Working With Physicians

Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Jobs
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • 2023 Salary Survey
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists